BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29391602)

  • 1. Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis.
    Park J; Kim J; Park B; Yang KM; Sun EJ; Tognon CE; Sorensen PH; Kim SJ
    Oncogene; 2018 Apr; 37(17):2270-2284. PubMed ID: 29391602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
    Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
    Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular transformation and activation of the phosphoinositide-3-kinase-Akt cascade by the ETV6-NTRK3 chimeric tyrosine kinase requires c-Src.
    Jin W; Yun C; Hobbie A; Martin MJ; Sorensen PH; Kim SJ
    Cancer Res; 2007 Apr; 67(7):3192-200. PubMed ID: 17409427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
    Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
    J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
    Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
    Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
    Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
    Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
    Chen S; Nagel S; Schneider B; Dai H; Geffers R; Kaufmann M; Meyer C; Pommerenke C; Thress KS; Li J; Quentmeier H; Drexler HG; MacLeod RAF
    Cell Oncol (Dordr); 2018 Feb; 41(1):93-101. PubMed ID: 29119387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.
    Lannon CL; Sorensen PH
    Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.
    Jiang Y; Yu M; Hu X; Han L; Yang K; Ba H; Zhang Z; Yin B; Yang XP; Li Z; Wang J
    Cell Death Differ; 2017 Apr; 24(4):660-671. PubMed ID: 28186502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFR-β-activated ACK1-AKT signaling promotes glioma tumorigenesis.
    Zhang J; Chen T; Mao Q; Lin J; Jia J; Li S; Xiong W; Lin Y; Liu Z; Liu X; Zhao H; Wang G; Zheng D; Qiu S; Ge J
    Int J Cancer; 2015 Apr; 136(8):1769-80. PubMed ID: 25257795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412.
    Chi HT; Ly BT; Kano Y; Tojo A; Watanabe T; Sato Y
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):87-92. PubMed ID: 23131561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis.
    Liu S; Yu X; Wang Q; Liu Z; Xiao Q; Hou P; Hu Y; Hou W; Yang Z; Guo D; Chen S
    J Microbiol Biotechnol; 2017 Oct; 27(10):1855-1866. PubMed ID: 28838224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
    Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
    Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.